priors.science/reviews/cardiovascular-inflammation-secondary-prevention

Cardiovascular Inflammation Secondary Prevention

The current evidence on 8 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

8claims tracked
91primary papers reviewed
9 Aug 2026latest evidence review
Weeklyre-scored against new papers
4 Established · 2 Likely · 2 Uncertain · 0 Doubtful  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
High-sensitivity C-reactive protein predicts major adverse cardiovascular events beyond low-density lipoprotein controlHsCRP Residual RiskEstablished88%14
IL-6 predicts major adverse cardiovascular events in coronary patientsCytokine TargetingEstablished86%16
Colchicine major adverse cardiovascular events in chronic coronary diseaseAnti Inflammatory AgentsEstablished85%15
Residual inflammatory risk post-myocardial infarctionHsCRP Residual RiskEstablished85%12
IL-1 beta inhibition reduces major adverse cardiovascular eventsCytokine TargetingLong-standingLikely84%13
Methotrexate null for cardiovascular preventionAnti Inflammatory AgentsLikely80%12
Colchicine major adverse cardiovascular events post-myocardial infarctionAnti Inflammatory AgentsUncertain68%16
IL-6 inhibition reduces major adverse cardiovascular events in chronic kidney diseaseCytokine TargetingUncertain56%10
Track Cardiovascular Inflammation Secondary Prevention.
These claims are re-scored against new papers every week. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it — confidently false as stated.
Where the evidence sits in time
Long-standingMost of this evidence is older than the rest of this field.